Showing 1 to 3 of 3 results


Funding Crisis Threatens English Pharmacies: Potential Service Reductions Looming
Facing unconfirmed funding for 2024-25 and 2025-26, England's 6,000 independent pharmacies may slash opening hours, impacting patient access to vital services, following 1,300 closures since 2017 due to insufficient funding and rising operational costs.
Funding Crisis Threatens English Pharmacies: Potential Service Reductions Looming
Facing unconfirmed funding for 2024-25 and 2025-26, England's 6,000 independent pharmacies may slash opening hours, impacting patient access to vital services, following 1,300 closures since 2017 due to insufficient funding and rising operational costs.
Progress
48% Bias Score


Walgreens Explores Privatization Amid US Pharmacy Industry Crisis
Walgreens, facing financial difficulties and decreased profitability, is reportedly considering going private amid a wider struggle in the US pharmacy industry that disproportionately affects minority communities, and is marked by decreased prescription drug reimbursement rates and increased online ...
Walgreens Explores Privatization Amid US Pharmacy Industry Crisis
Walgreens, facing financial difficulties and decreased profitability, is reportedly considering going private amid a wider struggle in the US pharmacy industry that disproportionately affects minority communities, and is marked by decreased prescription drug reimbursement rates and increased online ...
Progress
40% Bias Score

German Pharmacies at 50-Year Low Amidst Funding Crisis and Leadership Disputes
Germany's pharmacies have reached their lowest number in almost 50 years, with 17,041 at the end of 2024, down 530 from 2023, due to chronic underfunding and internal disputes within the industry's representative association, resulting in reduced patient access to essential medications.

German Pharmacies at 50-Year Low Amidst Funding Crisis and Leadership Disputes
Germany's pharmacies have reached their lowest number in almost 50 years, with 17,041 at the end of 2024, down 530 from 2023, due to chronic underfunding and internal disputes within the industry's representative association, resulting in reduced patient access to essential medications.
Progress
48% Bias Score
Showing 1 to 3 of 3 results